Vimarsana
Biggest News Aggregation in the World

Page 7 - Anders Rylander News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Anders Rylander. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Anders Rylander Today - Breaking & Trending Today

Biovica International: Q2 Interim Report August-October 2022/2023 - Vimarsana News

Biovica International: Q2 Interim Report August-October 2022/2023

UPPSALA, SE / ACCESSWIRE / December 15, 2022 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Successful capital acquisition paves the way for launch in the USASEK tQ2 22/23Q2 21/22May-Oct

Biovica International: Biovica Establishes Experienced US Sales Team - Vimarsana News

Biovica International: Biovica Establishes Experienced US Sales Team

UPPSALA, SE / ACCESSWIRE / December 1, 2022 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) Biovica, active in cancer diagnostics, today announces that the company has employed a sales

Biovica Establishes Experienced US Sales Team - Vimarsana News

Biovica Establishes Experienced US Sales Team

01.12.2022 - UPPSALA, SE / ACCESSWIRE / December 1, 2022 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) Biovica, active in cancer diagnostics, today announces that the company has employed a sales team of total of eight people to secure a fast ...

Biovica International: Biovica's DiviTum TKa Results Presented at SABCS - Vimarsana News

Biovica International: Biovica's DiviTum TKa Results Presented at SABCS

UPPSALA, SE / ACCESSWIRE / November 22, 2022 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) Biovica, active in cancer monitoring, today announces that results from a study using the DiviTum®

Biovica International: Biovica's DiviTum TKa featured in TK IMPACT study at SABCS - Vimarsana News

Biovica International: Biovica's DiviTum TKa featured in TK IMPACT study at SABCS

UPPSALA, SE / ACCESSWIRE / November 22, 2022 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) Biovica, active in cancer monitoring, today announces that the unique study design of the TK